ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,450,304 | +24.9% | 35,757 | +1.7% | 0.03% | +20.8% |
| Q3 2022 | $1,161,000 | +6.2% | 35,143 | +13.2% | 0.02% | +14.3% |
| Q2 2022 | $1,093,000 | -24.1% | 31,047 | -0.9% | 0.02% | -4.5% |
| Q1 2022 | $1,441,000 | -40.6% | 31,326 | -14.3% | 0.02% | -37.1% |
| Q4 2021 | $2,424,000 | -22.4% | 36,557 | -3.0% | 0.04% | -28.6% |
| Q3 2021 | $3,123,000 | 0.0% | 37,705 | 0.0% | 0.05% | +19.5% |
| Q2 2021 | $3,123,000 | +33.1% | 37,705 | +6.5% | 0.04% | +17.1% |
| Q1 2021 | $2,347,000 | -56.9% | 35,392 | -50.1% | 0.04% | -58.3% |
| Q4 2020 | $5,442,000 | +246.8% | 70,920 | +94.6% | 0.08% | +211.1% |
| Q3 2020 | $1,569,000 | – | 36,438 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |